| P50 | author | Gregory F. Oxenkrug | Q47202727 |
| P2093 | author name string | Oxenkrug G | |
| P2860 | cites work | The catecholamine hypothesis of affective disorders: a review of supporting evidence | Q22306296 |
| | Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats | Q73033887 |
| | The effect of nifedipine, Ca(2+) antagonist, on activity of MAO inhibitors, N-acetylserotonin and melatonin in the mouse tail suspension test | Q73701051 |
| | The conversion of kynurenic acid to quinaldic acid by humans and rats | Q74330431 |
| | Diabetogenic activity of xanturenic acid determined by its chelating properties? | Q77325464 |
| | Dehydroxylation of xanthurenic acid to 8-hydroxy-quinaldic acid | Q78279296 |
| | Neurotrophins: possible role in affective disorders | Q78440729 |
| | Kynurenine-transaminase, kynureninase and the increase of xanthurenic acid excretion | Q79454466 |
| | N-acetylserotonin activates TrkB receptor in a circadian rhythm | Q24623798 |
| | Kynurenines in the mammalian brain: when physiology meets pathology | Q27003296 |
| | Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review | Q28139785 |
| | Mitochondria as a target for neurotoxins and neuroprotective agents | Q28186231 |
| | Biosynthesis of melatonin: enzymic conversion of serotonin to N-acetylserotonin | Q28187610 |
| | The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease | Q28239367 |
| | N-acetylserotonin and hypotensive effect of MAO-A inhibitors | Q28264814 |
| | Differential proteomic profiling of mitochondria from Podospora anserina, rat and human reveals distinct patterns of age-related oxidative changes. | Q30833262 |
| | Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling | Q33792422 |
| | The role of neopterin in atherogenesis and cardiovascular risk assessment. | Q34020110 |
| | The treatment of depressive states with G 22355 (imipramine hydrochloride). | Q34244691 |
| | Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis | Q34327755 |
| | The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine | Q34455273 |
| | Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later | Q34495694 |
| | Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders | Q34520722 |
| | Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect | Q34661622 |
| | Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine | Q34705720 |
| | Immune system to brain signaling: neuropsychopharmacological implications. | Q34769827 |
| | Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression | Q34812879 |
| | Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism | Q35694510 |
| | Neopterin, a Marker of Interferon-Gamma-Inducible Inflammation, Correlates with Pyridoxal-5'-Phosphate, Waist Circumference, HDL-Cholesterol, Insulin Resistance and Mortality Risk in Adult Boston Community Dwellers of Puerto Rican Origin | Q35720151 |
| | Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders. | Q35806777 |
| | Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety | Q35810557 |
| | Berberine Prolongs Life Span and Stimulates Locomotor Activity of Drosophila melanogaster | Q35838662 |
| | Neopterin as a marker of response to antiviral therapy in hepatitis C virus patients | Q36090631 |
| | N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain | Q36173713 |
| | Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications. | Q36265321 |
| | N-acetylserotonin and aging-associated cognitive impairment and depression. | Q36409066 |
| | Minocycline effect on life and health span of Drosophila melanogaster | Q36409142 |
| | Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. | Q37031204 |
| | Chronic immune stimulation correlates with reduced phenylalanine turnover | Q37264638 |
| | Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism | Q37349845 |
| | Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status | Q37474800 |
| | Identification of tryptophan metabolites in the healthy epidermis of diabetics | Q67049697 |
| | Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice | Q67318707 |
| | Depressor effect of kynurenine and its metabolites in rats | Q67868281 |
| | Effect of quinolinic acid on wakefulness and sleep in the rabbit | Q68428425 |
| | Circadian rhythms of human pineal melatonin, related indoles, and beta adrenoreceptors: post-mortem evaluation | Q68484267 |
| | The frog as a subject for screening thymoleptic drugs | Q68749215 |
| | Urinary excretion of xanthurenic acid and zinc in diabetes: (3). Occurrence of xanthurenic acid-Zn2+ complex in urine of diabetic patients and of experimentally-diabetic rats | Q69663423 |
| | 3-Hydroxykynurenine, 3-hydroxyanthranilic acid, and o-aminophenol inhibit leucine-stimulated insulin release from rat pancreatic islets | Q69882284 |
| | Effect of kynurenine and quinolinic acid on the action of convulsants in mice | Q71277970 |
| | Dissimilar influences of imipramine, benactyzine and promazine on effects of micro-injections of noradrenaline, acetylcholine and serotonin into the amygdala in the cat | Q71344105 |
| | [The development of vomiting under the influence of microinjections of serotonin into the hypothalamus, septum and amygdala of cats having previously received imipramine] | Q72322217 |
| | Tryptophan metabolism in affective psychoses | Q72772296 |
| | Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression | Q72775115 |
| | Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism | Q37772960 |
| | Kynurenines as probable participants of depression | Q39944722 |
| | Norepinephrine in depressive reactions. A review | Q40028374 |
| | N-Acetylserotonin in the central nervous system | Q40076108 |
| | Structure-activity relationships in kynurenine, diazepam and some putative endogenous ligands of the benzodiazepine receptors | Q40136304 |
| | Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine | Q40369905 |
| | Melatonin rhythmicity: effect of age and Alzheimer's disease | Q40609056 |
| | Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets | Q41028375 |
| | Scotophobin A causes dark avoidance in goldfish by elevating pineal N-acetylserotonin | Q41035473 |
| | Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro | Q41252647 |
| | Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid | Q41480425 |
| | Generation of superoxide by purified brain nitric oxide synthase | Q41590269 |
| | Chronic fluoxetine administration increases the serotonin N-acetyltransferase messenger RNA content in rat hippocampus | Q42536216 |
| | Quinone reductase 2 and antidepressant effect of melatonin derivatives | Q42969537 |
| | Properties and function of indoleamine 2,3-dioxygenase | Q43407543 |
| | Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA) | Q43417381 |
| | Depressed States and Indolealkylamines | Q43569583 |
| | Tryptophan metabolism in vitamin B6-deficient mice | Q43578101 |
| | Antioxidant and antiaging activity of N-acetylserotonin and melatonin in the in vivo models | Q43681262 |
| | Analgesia induced by N-acetylserotonin in the central nervous system | Q43691740 |
| | Differential effects of lipopolysaccharide on lipid peroxidation in F344N, SHR rats and BALB/c mice, and protection of melatonin and NAS against its toxicity | Q44508346 |
| | Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. | Q45012456 |
| | Convulsions and tremor in immature rats after intraperitoneal injection of kynurenine and its metabolites | Q45113875 |
| | Difference spectra for inhibitor binding to monoamine oxidases | Q46280452 |
| | MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate | Q46338960 |
| | N-acetyldopamine inhibits rat brain lipid peroxidation induced by lipopolysaccharide | Q46716802 |
| | Effect of methylene blue and related redox dyes on monoamine oxidase activity; rat pineal content of N-acetylserotonin, melatonin, and related indoles; and righting reflex in melatonin-primed frogs. | Q46852289 |
| | Georges Ungar and memory transfer | Q46885358 |
| | Kynurenine and hypotension: historic perspectives | Q47202685 |
| | Melatonin, Circadian Rhythms, and Sleep | Q47999885 |
| | The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesis | Q48223162 |
| | The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats. | Q48223244 |
| | Differential localization of N-acetylated indolealkylamines in CNS and the Harderian gland using immunohistology | Q48343189 |
| | Antagonism of kynurenic acid to anxiogens in mice | Q48377827 |
| | Changes with age in daytime and nighttime contents of melatonin, indoleamines, and catecholamines in the pineal gland: a comparative study in rat and Syrian hamster | Q48385621 |
| | Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice | Q48477920 |
| | B-adrenergic regulation of N-acetylserotonin (NAS) synthesis in the rat cerebellium | Q48738702 |
| | Isolation, Identification and Synthesis of a specific-behaviour-inducing Brain Peptide | Q48740347 |
| | Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease | Q48819579 |
| | Negative emotions and 3-year progression of subclinical atherosclerosis. | Q50910771 |
| | Depression and risk for onset of type II diabetes. A prospective population-based study. | Q50997140 |
| | Effect of dimethyl and monomethyl tricyclic antidepressants on central 5-hydroxytryptamine processes in the frog. | Q51116682 |
| | Synthetic scotophobin: analysis of behavioral effects on mice. | Q51306426 |
| | Studies on the urinary excretion of xanthurenic acid in diabetics. | Q51644117 |
| | Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. | Q51856580 |
| | N-acetylserotonin, melatonin and their derivatives improve cognition and protect against beta-amyloid-induced neurotoxicity. | Q52171052 |
| | Kynurenines and Seizures | Q53837685 |
| | Proceedings: Antagonism of nicotinic acid and other kynurenines to antidepressants: one of the probable reasons of the therapy-resistance in depression? | Q54150171 |
| | Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin | Q59009915 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 514-521 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Current Drug Targets | Q15724627 |
| P1476 | title | Serotonin-kynurenine hypothesis of depression: historical overview and recent developments | |
| P478 | volume | 14 | |